934715-85-2

Upstream product

• 934715-66-9 2-(2-{2-[6-benzyloxycarbonylamino-2-(2-tert-butoxycarbonylamino-4-methyl-pentanoylamino)-hexanoylamino]-3-methyl-butyrylamino}-4-methyl-pentanoylamino)-3-phenyl-propionic acid methyl ester 
• 934715-65-8 (S)-2-[(S)-2-((S)-2-Amino-3-methyl-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid methyl ester 
• 863781-33-3 Boc-Val-Leu-Phe-OMe 
• 13139-15-6 N-tert-butoxycarbonyl-L-leucine 
• 24498-31-5 (S)-methyl 2-amino-6-(benzyloxycarbonylamino)hexanoate 
• 2577-90-4 methyl (2S)-2-amino-3-phenylpropanoate 
• 37571-13-4 Boc-Leu-Lys(Z)-OH 
• 37571-12-3 N-tert-butoxycarbonyl-L-leucyl-L-(N-ε-benzyloxycarbonyl)lysine methyl ester 
• 15136-32-0 (N-(tert-butoxycarbonyl)-L-leucinyl)-L-phenylalanine methyl ester 
• 38155-18-9 L-leucyl-L-phenylalanine methyl ester 

Downstream Products

• 934715-06-7 [4-(11-benzyl-8,14-diisobutyl-5-isopropyl-3,6,9,12,15-pentaoxo-1,4,7,10,13pentaaza-cyclopentadec-2-yl)-butyl]-carbamic acid benzyl ester 

Relevant academic research and scientific papers

Synthesis of second-generation Sansalvamide A derivatives: Novel templates as potential antitumor agents

We report the synthesis of 34 second-generation Sansalvamide A derivatives. San A derivatives have unique anticancer properties and target multiple cancers, including colon, pancreatic, breast, prostate, and melanoma. As novel templates, the derivatives d